IC
JNJ icon

Inscription Capital’s Johnson & Johnson JNJ Stock Holding History

Inscription Capital’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.65M Sell
27,207
-664
-2% -$155K 0.7% 27
2025
Q4 		$5.77M Buy
27,871
+1,566
+6% +$310K 0.59% 28
2025
Q3 		$4.88M Buy
26,305
+3,732
+17% +$639K 0.53% 32
2025
Q2 		$3.45M Sell
22,573
-1,845
-8% -$284K 0.5% 36
2025
Q1 		$3.86M Buy
+24,418
New +$3.82M 0.64% 28
2024
Q3 		$3.6M Sell
22,210
-1,503
-6% -$239K 0.53% 36
2024
Q2 		$3.47M Sell
23,713
-705
-3% -$105K 0.56% 35
2024
Q1 		$3.86M Buy
24,418
+2,748
+13% +$437K 0.64% 28
2023
Q4 		$3.4M Buy
21,670
+936
+5% +$144K 0.93% 20
2023
Q3 		$3.23M Sell
20,734
-812
-4% -$134K 1.05% 18
2023
Q2 		$3.57M Buy
21,546
+83
+0.4% +$13.4K 1.11% 16
2023
Q1 		$3.33M Sell
21,463
-285
-1% -$46K 0.88% 20
2022
Q4 		$3.84M Buy
21,748
+75
+0.3% +$12.9K 1.31% 14
2022
Q3 		$3.54M Sell
21,673
-68,007
-76% -$11.5M 1% 17
2022
Q2 		$15.9M Buy
89,680
+68,387
+321% +$12.2M 2.87% 5
2022
Q1 		$3.77M Sell
21,293
-374
-2% -$63.6K 1.08% 17
2021
Q4 		$3.71M Buy
21,667
+2,102
+11% +$344K 1.01% 23
2021
Q3 		$3.16M Sell
19,565
-89,615
-82% -$15.3M 0.99% 20
2021
Q2 		$18M Buy
109,180
+90,617
+488% +$15M 2.04% 8
2021
Q1 		$3.05M Sell
18,563
-560
-3% -$90.6K 1.04% 15
2020
Q4 		$3.01M Buy
19,123
+1,041
+6% +$154K 1.16% 16
2020
Q3 		$2.69M Sell
18,082
-151
-0.8% -$22.3K 1.19% 17
2020
Q2 		$2.56M Buy
18,233
+1,385
+8% +$202K 1.42% 15
2020
Q1 		$2.21M Buy
16,848
+482
+3% +$68.4K 1.47% 15
2019
Q4 		$2.39M Buy
16,366
+3,361
+26% +$456K 1.06% 23
2019
Q3 		$1.68M Buy
13,005
+9,813
+307% +$1.29M 0.93% 26
2019
Q2 		$415K Sell
3,192
-1,590
-33% -$220K 0.31% 66
2019
Q1 		$668K Buy
4,782
+972
+26% +$130K 0.35% 53
2018
Q4 		$492K Buy
+3,810
New +$531K 0.27% 67

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Inscription Capital's JNJ Position: Q1 2026 in Review

Inscription Capital reduced its Johnson & Johnson (JNJ) stake by 2.4% in Q1 2026, selling an estimated $155K and leaving 27,207 shares worth $6.65M. The position accounts for 0.7% of the portfolio, ranked #27.

Inscription Capital first reported a position in JNJ in Q4 2018 and has held it in 29 quarters since. The position peaked at $18M in Q2 2021. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Inscription Capital held 27,207 shares of Johnson & Johnson worth $6.65M as of Q1 2026.
  • Inscription Capital sold 664 Johnson & Johnson shares in Q1 2026, an estimated $155K.
  • Johnson & Johnson made up 0.7% of Inscription Capital's portfolio in Q1 2026, its #27 holding.
  • Inscription Capital first reported a position in Johnson & Johnson in Q4 2018 and has held it in 29 quarters since.
  • Inscription Capital's Johnson & Johnson position peaked at $18M in Q2 2021.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Inscription Capital's 13F filing for Q1 2026, filed 20 Apr 2026.